NSE: HINDUNILVR · BSE: 500696
HINDUSTAN UNILEVER LTD.
Sells everyday consumer goods across four main categories in India — Home Care, Foods, Beauty & Wellbeing, and Personal Care — through a network of more than 9 million retail outlets, with the Shikhar eB2B platform handling over one-third of sales. Home Care is the largest segment at Rs. 23,689 cr (37.5% of FY26 segment revenue), covering laundry, cleaning and dishwash products such as Vim Liquid and Dove. Foods contributed Rs. 14,061 cr (22.2%), spanning nutrition and staples including Horlicks Superfoods relaunched in South India. Beauty & Wellbeing generated Rs. 13,684 cr (21.6%), covering skin care, hair care and masstige brands such as Vaseline (which crossed Rs. 1,000 cr), Minimalist, OZiva, Simple and Nexus. Personal Care added Rs. 9,567 cr (15.1%). FY26 consolidated turnover was Rs. 63,763 cr with 5% underlying sales growth and a 24.15% EBITDA margin. Q1 FY27 sales grew 10%, led by Home Care at 14%. Materials are the largest cost line at 32.5% of revenue, currently hit by 8-10% inflation tied to Middle East supply disruption. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Home Care (38%), Foods (22%), Beauty & Wellbeing (22%), Personal Care (15%), Discontinued operations (2%), Others (includes Exports) (2%). Diversified, branded FMCG with volume-led growth and a portfolio premiumisation push
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 52,446 | 60,580 | 61,896 | 63,121 | 64,468 |
| EBITDA (ex other income) | 12,813 | 14,085 | 14,669 | 15,156 | 14,819 |
| margin % | 24.4 | 23.3 | 23.7 | 24.0 | 23.0 |
| Owners' profit | 8,879 | 10,120 | 10,277 | 10,649 | 15,040 |
| EPS, as reported (₹) | 37.79 | 43.07 | 43.74 | 45.32 | 64.01 |
| ROE % · ROCE % | 18.1 · 20.2 | 20.1 · 22.0 | 20.0 · 21.7 | 21.5 · 23.4 | 30.7 · 22.2 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 9,048 | 9,991 | 15,469 | 11,886 | 10,999 |
| Capex | (1,225) | (1,174) | (1,468) | (1,254) | (1,258) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15,926 | 15,818 | 15,670 | 16,514 | 16,241 | 16,441 | 16,351 | 17,341 |
| Profit before tax | 3,548 | 3,981 | 3,363 | 3,304 | 3,573 | 2,926 | 3,928 | 3,632 |
| Net profit | 2,595 | 2,989 | 2,475 | 2,768 | 2,694 | 6,603 | 2,994 | 2,680 |
| EPS (₹) | 11.03 | 12.70 | 10.48 | 11.73 | 11.43 | 28.12 | 12.73 | 11.38 |
Exhibit 3: Segment revenue, FY26
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Home Care | 23,672 | 36.0 |
| Beauty & Wellbeing | 14,990 | 22.8 |
| Personal Care | 9,564 | 14.6 |
| Foods | 15,140 | 23.0 |
| Others (includes Exports) | 2,181 | 3.3 |
| Discontinued operations | 178 | 0.3 |
| Total, before eliminations | 65,725 | 100.0 |
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| HINDUSTAN UNILEVER LTD. ◆ | 4,26,713 | 28.5 | 8.71 | 27.2 | 30.7 | 21.5 | 6.5 | 23.4 |
| ITC LTD | 3,25,141 | 16.4 | 4.46 | 11.1 | 28.8 | 35.9 | 11.1 | 21.1 |
| HINDUSTAN FOODS LIMITED | 6,666 | 42.5 | 5.72 | 20.6 | 12.8 | 9.8 | 25.1 | 8.8 |
| GODAVARI BIOREFINERIES L | 1,030 | 6707.7 | 1.31 | 14.3 | 0.4 | 0.4 | — | 0.5 |
| RANA SUGARS LTD. | 180 | 31.6 | 0.30 | — | 4.0 | 4.9 | — | (1.7) |
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 28.5 | 17.8 | 187 of 278 | 33% |
| P/B | 8.7 | 1.7 | 256 of 281 | 9% |
| ROCE | 21.5 | 7.5 | 44 of 331 | 87% |
| ROE | 30.7 | 7.3 | 19 of 283 | 94% |
| Debt / Equity | 0.0 | 0.3 | 1 of 281 | 85% |
| EBITDA margin | 23.4 | 8.3 | 41 of 272 | 85% |
| Revenue growth | 5.0 | 9.8 | 162 of 273 | 41% |
| Profit growth | (3.2) | 12.9 | 170 of 276 | 39% |
| Market cap | 426713 | 160 | 1 of 341 | 100% |
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 28 Oct 2026 · HUL publishes earnings call recording for September 2026 quarter | investor communications | low | — | — |
| 28 Oct 2026 · Brazilian step-down subsidiary completes voluntary liquidation | strategic transactions | low | — | — |
| 28 Oct 2026 · Rs 19 interim dividend; record date 12 November 2026 | corporate actions | high | — | — |
| 28 Oct 2026 · September quarter sales up 15%; EBITDA margin down, Rs 19 dividend declared | results | high | — | — |
| 28 Oct 2026 · HUL declares Rs 19 interim dividend; record date 12 Nov 2026 | corporate actions | high | — | — |
| 28 Oct 2026 · HUL posts 15% sales growth in Sep quarter, declares Rs 19 dividend | compliance | minimal | — | — |
| 28 Oct 2026 · Q2 sales rise 15%; Rs 19 interim dividend declared | corporate actions | high | — | — |
| 26 Oct 2026 · HUL reopens window for re-lodging physical share transfer requests | compliance | minimal | — | — |
| 21 Oct 2026 · HUL to hold earnings call on 28 October 2026 | board shareholder meetings | low | — | — |
| 9 Oct 2026 · HUL board meeting on Oct 28 to consider Q2 results and interim dividend | compliance | minimal | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.